Watchlist

Watchlist
Matinas Biopharma Holdings, Inc. (MTNB)
Matinas Biopharma Holdings, Inc. (MTNB)
European advisory group rescinds authorization for omega-3 fatty acid meds for use after heart attacks
Citing the lack of evidence that they work for the indication, the European Medicines Agency's advisory group CHMP has withdrawn its authorization for the use of omega-3 fatty acid medications to prevent further heart and blood vessel problems in heart attack patients. The meds have been a…
Matinas Biopharma Holdings, Inc. (MTNB)
Matinas Biopharma Holdings, Inc. (MTNB)